BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 30732963)

  • 1. Proposals for the delineation of neck clinical target volume for definitive Radiation therapy in patients with oral/ oropharyngeal squamous cell cancer based on lymph node distribution.
    Liu YC; Zhang X; Yang HN; Zhang L; Li D; Yang MQ; Wang NH; Wu YZ; Sui JD; Wang Y
    Radiother Oncol; 2024 Jun; 195():110225. PubMed ID: 38490491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Submandibular Gland in Neck Dissection: Necessary Fatality or Unfortunate Prey?
    Rahman T; Khandelwal K; Bannoth S; Kumar Das A; Das R; Das K; Das A; Kakati K
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):789-793. PubMed ID: 37275085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questionable Necessity for Removing Submandibular Gland in Neck Dissection in Squamous Cell Carcinoma of Oral Cavity.
    Agarwal G; Nagpure PS; Chavan SS
    Indian J Otolaryngol Head Neck Surg; 2016 Sep; 68(3):314-6. PubMed ID: 27508132
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhao L; Zhu Y; Zhang L; Huang Y; Fan Y; Gao L; Zhao Y; Wang X; Mo D; Lu H; Wang D
    Heliyon; 2024 May; 10(10):e31005. PubMed ID: 38799761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
    Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
    Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submandibular gland involvement in oral cavity squamous cell carcinoma: a retrospective multicenter study.
    Iocca O; Copelli C; Garzino-Demo P; Ramieri G; Rubattino S; Sedran L; Volpe F; Manfuso A; Longo F; Sanchez-Aniceto G; Rivero-Calle Á; García-Sánchez A; Pellini R; Petruzzi G; Moretto S; Al-Qamachi L; Aga H; Ridley S; Di Maio P
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4205-4214. PubMed ID: 37280380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis.
    Kim D; Keam B; Ahn SH; Choi CH; Wu HG
    Radiat Oncol J; 2022 Dec; 40(4):260-269. PubMed ID: 36606303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective Submandibular Gland Resection in Patients with Squamous Cell Carcinomas of the Tongue.
    Javadi S; Khademi B; Mohamadianpanah M; Shishegar M; Babaei A
    Iran J Otorhinolaryngol; 2021 Jan; 33(114):23-29. PubMed ID: 33654687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submandibular gland-sparing intensity-modulated radiotherapy.
    Mendenhall WM; Mendenhall CM; Mendenhall NP
    Am J Clin Oncol; 2014 Oct; 37(5):514-6. PubMed ID: 22892434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy: is xerostomia still prevalent?
    Chambers MS; Garden AS; Rosenthal D; Ahamad A; Schwartz DL; Blanco AI; Chao KS; Morrison WH; Ang KK; Weber RS
    Curr Oncol Rep; 2005 Mar; 7(2):131-6. PubMed ID: 15717947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective.
    Varra V; Ross RB; Juloori A; Campbell S; Tom MC; Joshi NP; Woody NM; Ward MC; Xia P; Koyfman SA; Greskovich JF
    Oral Oncol; 2019 Feb; 89():79-83. PubMed ID: 30732963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
    Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
    Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
    Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
    Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
    Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
    Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
    Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
    Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.